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INTRODUCTION 
          Ascites is the pathological accumulation of fluid within the 
peritoneal cavity. It is one of the most common amongst the various 
clinical conditions, confronting not only a physician, but a surgeon 
and a gynaecologist too. It complicates a variety of disorders (1) which 
include cirrhosis, decompensated heart failure, nephrotic syndrome, 
peritoneal tuberculosis, disseminated carcinomatosis, pancreatitis, 
myxedema etc. In these conditions, ascites develops only as a 
consequence of the underlying illness. So the evaluation of the 
patients with ascites requires, that the cause of ascites be established. 
A proper diagnosis is a prerequisite for the successful management of 
these patients. 
             Diagnostic ascitic fluid aspiration is the most rapid and cost 
effective test for identifying the basic disease process. Before the 
1980s, the ascitic fluid total protein [AFTP] concentration was used to 
classify ascites as either exudative [AFTP>/= 2.5 g/dl] or 
transudative [AFTP<2.5g/dl] (3).This classification is unable to 
correctly identify the etiological factors responsible for its causation. 
Hence this antiquated system of ascitic fluid classification is 
 2
problematic and it offers only a little insight to the pathophysiology 
of the ascitic fluid formation. 
                Further, these drawbacks led to the development of a new 
approach to classify ascites, based on the difference between the 
serum and ascitic fluid albumin concentration [Serum Ascites 
Albumin Gradient – SAAG] . This newer concept classified ascites 
into two categories – High SAAG ascites with SAAG >/= 1.1 g/dl in 
cases with portal hypertension and Low SAAG ascites with SAAG < 
1.1 g/dl in cases with ascites, unrelated to portal hypertension. 
                The serum ascites albumin gradient has been proved in 
multiple studies to categorize ascites better than either the ascitic 
fluid total protein or other parameters in ascitic fluid analysis. In 
view of the above, the present study is undertaken among the 
inpatients, admitted with ascites in the medical wards of Tirunelveli 
Medical College Hospital, to evaluate the value of SAAG in the 
etiological diagnosis of ascites and also to compare its sensitivity and 
diagnostic accuracy with that of ascitic fluid total protein [AFTP].       
 
 
 
 3
AIM OF THE STUDY 
 
1. To differentiate ascites on the basis of serum ascites albumin 
gradient into high SAAG ascites > 1.1 g/dl and low SAAG 
ascites < 1.1 g/dl. 
2. To determine the sensitivity and specificity of serum ascites 
albumin gradient and that of ascitic fluid total protein, in 
identifying the etiology of ascites. 
3. To compare the diagnostic accuracy of serum ascites albumin 
gradient with the traditional marker – ascitic fluid total protein.   
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REVIEW OF LITERATURE 
Historical Perspective:- 
Ascites is mentioned even in the most ancient of medical texts, 
i.e. the papyrus Ebers of Ancient Egypt and the ayurveda of Hindu 
tradition (Jalodara), both dating from as early as 1500-1600 BC (9)
 The term “Ascites” first appeared in English in the late 14th 
century as Aschytes and was taken from the Greek word for dropsy 
‘askitos’ [bladder, belly or bag], itself derived from  an ancient Greek 
word for a leather bag or sheep skin, that was used for carrying 
water, wine, oil and so on.(9)
Anatomy of the Peritoneal Cavity:- 
        The peritoneal cavity is lined by the peritoneal membrane, that  
is composed of flattened polyhedral cells (mesothelium), one layer 
thick, resting upon a thin layer of fibroelastic tissue. Beneath the 
membrane, supported by a small amount of areolar tissue, lies a 
network of lymphatic vessels and rich plexuses of capillary blood 
vessels from which all absorption and exudation must occur. This 
membrane is a semipermeable one (7),(8).
       The peritoneal membrane comprises of two components in 
continuity –  
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1. The visceral peritoneum covering the abdominal organs  
          2. The parietal peritoneum lining the abdominal wall. 
           The peritoneal cavity is thus a closed sac except for the 
fimbriated ends of the fallopian tubes and is the largest cavity in the 
body, with a total surface area of approximately 2 sq. m. In the 
normal healthy adult males, only a few ml of serous fluid is found in 
the peritoneal cavity, which provides a lubricant to allow the gliding 
movements of the viscera. Women may normally have as much as 20 
ml of fluid, depending on the phase of the menstrual cycle (15).            
Pathophysiology:- 
                   Ascites has fascinated doctors for many years and studies 
on its pathogenesis were initiated as long ago, as the seventeenth 
century. Richard Lower et al. (1631 – 1691), a physician, based in 
Oxford, demonstrated that ascites developed in dogs following 
ligation of inferior vena cava.  Ernest Henry Starling et al. (1866 – 
1927), a physiologist , based at University College, London made the 
greatest contribution to the study of oedema formation with the 
demonstration, that  both lymphatic forces and oncotic forces were 
involved (5).      
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Starling‘s hypothesis: (12),(13) 
                  The great British Physiologist E. H. Starling et al. in the 
early 20th century proposed the principle of movement of fluids from 
and to the capillaries. The primary forces that determine the fluid 
movement are termed Starling’s forces in honour of him, who first 
demonstrated their importance.  They are 
1. The capillary pressure which tends to force fluid outward 
through the capillary membrane. 
2. The interstitial fluid pressure which tends to force fluid inward 
through the capillary. 
3. The capillary plasma colloid osmotic pressure which tends to 
cause osmosis of fluid inward through the capillary membrane.   
4. The interstitial fluid colloid osmotic pressure which tends to 
cause osmosis of fluid outward through the capillary 
membrane. 
This principle plays the major role in the pathogenesis of ascites.        
Under normal conditions (10), the amount of peritoneal fluid is 
determined by a balance of intravascular forces, which attempt to 
push the fluid off (hydrostatic pressure) and to hold the fluid within  
(colloid osmotic pressure dependent mainly on serum albumin), the 
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vascular compartment. Ascites occurs when there is either an 
alteration(23) in the physiologic forces in the form of increased 
hydrostatic pressure (Portal hypertension, Constrictive pericardits, 
Decompensated Heart failure) or decreased serum albumin 
(nephrotic syndrome, cirrhosis, kwashiorkor) or primary diseases of 
peritoneum.(20)  
Cirrhotic Ascites:(4),(27) 
Theories regarding the mechanism of ascites formation (4) 
               All proposed mechanisms involve inappropriate renal 
sodium and water retention either secondary to vascular changes 
(Underfill theory and Peripheral arterial vasodilatation theory) or as a 
primary event (Overfill theory) 
Sequence of events for the hypothesis of ascites formation:  
Sequence Underfill & 
Peripheral 
vasodilatation theory 
Overfill theory 
Primary Vascular Renal 
Secondary Renal Vascular 
   
 
 
 8
Underfill Theory: (4) 
          The traditional underfill theory proposed that the inappropriate 
sequestration of fluid within the splanchnic vascular bed, which 
along with peripheral vasodilatation, associated with arteriovenous 
shunting led to a reduction in the central vascular compartment. The 
consequent decrease in effective circulating blood volume activates 
the renin angiotensin aldosterone system (RAAS) resulting in renal 
sodium and water retention.  
 Overfill hypothesis:  
             The overfill theory(4) suggests that, the primary abnormality is 
a defect in sodium handling. The proposal responsible for this is that, 
there is a primary renal change responding to a hepatic signal, that 
leads to sodium retention. The suggested signals are 
a. Reduced hepatic synthesis of a natriuretic agent  
b. Reduced hepatic clearance of a sodium retaining hormone  
c. A Hepatorenal reflex of unknown etiology 
            The hypothesis proposed that the renal sodium and water 
retention leads to expansion of plasma volume, an increase in cardiac 
output and a fall in systemic vascular resistance.  
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Overfill theory:                                           
Hepatic signal 
↓ 
Renal sodium and water retention 
↓ 
Increased Plasma volume , ↑ Cardiac output 
↓ Systemic vascular resistance 
↓ 
Portal hypertension 
↓ 
Overflow into peritoneal cavity 
Peripheral vasodilatation theory: (Schrier et al. 1988) (5),(4),(32) 
 The most recent theory is the Peripheral arterial 
Vasodilatation(4) hypothesis which is a modification of overfill theory. 
Nitric oxide is thought to play a central role. This leads to net arterial 
vasodilatation, reduced arterial vascular resistance, increased cardiac  
output and reduced filling of the central vascular compartment. 
Splanchnic arterial vasodilatation is accompanied by vasoconstriction 
in the renal, cerebral and muscular vascular beds. The renin 
angiotensin aldosterone system and sympathetic activity are 
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increased. The vasodilatation theory proposes that underfill is 
operative early and overfill is operative late in the natural history of 
cirrhosis. 
         Peripheral arterial vasodilatation hypothesis for ascites 
formation in cirrhosis (4) 
Peripheral vasodilatation 
↓ 
Diminished effective arterial bood volume 
↓ 
Rise in Renin , Aldosterone, Vasopressin and Sympathetic stimulation 
↓ 
Sodium and water retention, Renal vasoconstriction 
↓ 
Plasma volume expansion + Portal hypertension 
↓ 
Ascites  
Vasodilators:  
           The factors responsible for splanchnic and arterial 
vasodilatation are not clearly understood. Endothelial cells may 
respond to changes in shear, stress, endotoxins or cytokines with the 
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production of vasodilators like nitric oxide. Nitric oxide synthesis is 
increased in cirrhotic patients. In an experimental model of cirrhosis, 
inhibition of nitric oxide synthase significantly reduced the plasma 
renin, aldosterone and vasopressin levels.  Another new potent 
vasodilator – Adrenomedullin may also play a role. Other 
vasodilators that play a minimal role are Prostaglandins, Prostacyclin,  
atrial natriuretic peptide and calcitonin gene related peptide 
 Regardless of the initiating events, other factors like 
hypoalbuminemia and increased splanchnic and hepatic lymph 
formation contribute to the accumulation of fluid into the abdominal 
cavity in cirrhotic cases. 
Noncirrhotic ascites :- 
Cardiac ascites (3),(27) 
                          Ascites can complicate high output or low output 
decompensated heart failure. As in cirrhosis, the effective arterial 
blood volume appears to be decreased and as a result the 
vasopressin, renin, aldosterone and sympathetic nervous systems are 
activated. These changes lead to renal vasoconstriction and sodium 
and water retention. Fluid then weeps from the congested hepatic 
sinusoids due to the increased sinusoidal pressure.  
 12
Malignant ascites (16),(35) 
               The mechanism of fluid retention in patients with 
malignancy related ascites depends on the location of the tumor and 
the ascites presents in one of four ways. 
1. Peripheral ascites -   Peritoneal carcinomatosis  
                 It is the most common presentation and constitutes about 
50% of cases. The mechanism of ascites formation in peritoneal 
carcinomatosis is through the production of proteinaceous fluid by 
the tumour cells lining the peritoneum. Extracellular fluid enters the 
peritoneal cavity to reestablish the oncotic pressure balance. 
2. Central ascites: 
 It constitutes about 15% of cases. It can be due to either a 
primary hepatocellular carcinoma or a secondary metastatic deposit 
in the liver. In patients with hepatocelluar carcinoma, ascites arises 
because of the underlying cirrhosis – related portal hypertension, 
tumor induced portal vein thrombosis or both. Fluid accumulates in 
patients with massive liver metastases because of portal hypertension 
caused by stenosis or occlusion of the portal vein by tumor nodules or 
tumor emboli. 
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3.Mixed ascites:  
                  It is due to the tumour deposits in the liver and the 
peritoneum 
4.Chylous ascites: 
                 It is due to the fluid accumulation from lymphatic invasion.       
Tuberculous ascites: (3)  
       Tuberculosis probably causes ascites due to the production 
of proteinaceous fluid, as in peritoneal carcinomatosis.  
Spontaneous bacterial peritonitis: (3),(24)  
                 It dose not appear to cause fluid to accumulate. Infection 
develops only in preexisting ascites. 
Pancreatic or Biliary ascites: ( 1),(3).
 In patients with pancreatic or biliary ascites,  fluid accumulates 
by leakage of pancreatic juice or bile into the peritoneal cavity, or 
from secondary to a ‘chemical burn’ of the peritoneum. The 
pancreatic fluid may extravasate from the pancreatic ductal system, 
most commonly from a leaking pseudocyst. After abdominal surgery 
especially extensive retroperitoneal dissection, lymphatics may be 
transected and may leak lymph for varying amounts of time. 
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Diagnosis :- (3),(33)
 Although the diagnosis of ascites may be suspected on the basis 
of the history and physical examination, final confirmation is based 
on successful abdominal paracentesis and detection of ascites on 
imaging. Determination of the cause is based on history, physical 
examination, ascites fluid analysis and imaging studies. 
 In a patient presenting with ascites, for the first time, analysis of 
ascitic fluid should be done to determine the underlying etiology and 
and then confirmed by imaging techniques. 
Ascitic fluid analysis (3) 
 The basic concept of ascitic fluid analysis is that the 
screening tests are performed on the initial specimen and additional 
testing is performed only when necessary as indicated by the results 
of the screening tests. On the basis of cost analysis, tests can be 
classified as routine, optional, unusual and unhelpful. 
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Routine Optional Unusual Unhelpful 
Cell count Culture TB Smear & 
Culture 
Ph 
Albumin Glucose Cytology Lactate 
Total 
protein 
LDH Triglyceride Cholesterol 
 Amylase Bilirubin Fibronectin 
 Gram stain  Alpha1 Antitrypsin 
   Glycosaminoglycans 
 
The two tests highlighted in this study are ascitic fluid total protein 
and ascitic fluid albumin to detect SAAG. 
Exudate / Transudate :- 
Ascitic fluid total protein. 
 In the past, the ascitic fluid total protein concentration was used 
to classify ascites as either exudative (greater than 2.5 g/dl) or 
transudative (less than 2.5 g/dl). 
Classification of ascites based on exudative / transudative(7)
I. Transudative ascites 
A. Hypoalbuminemia  
         1. Nephrotic syndrome 
         2.  Protein losing enteropathy 
 16
B. Venous hypertension 
1. Due to high right sided cardiac pressure: 
(i) Congestive heart failure 
(ii) Tricuspid insufficiency 
(iii) Constrictive Pericarditis 
2. Blockage of Hepatic veins and / or Vena cava 
(i) Hepatic vein blocks (Budd Chiari syndrome, 
webs, tumors)  
(ii) Veno occlusive disease 
C. Portal vein obstruction 
D. Diffuse Parenchymal disease with portal hypertension – All 
forms of Cirrhosis 
E. Infiltrative processes of the liver 
1. Tumours, Lymphomas, Myeloid metaplasia 
2. Granulomatous disease 
II. Exudative ascites 
A. Inflammatory diseases of the peritoneum  
1. Tuberculosis 
2. Bacterial Peritonitis 
3. Pancreatitis 
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4. Rupture of viscus with / without an intraabdominal mass. 
5. Bile peritonitis  
B. Malignant causes 
1. Metastases to liver or peritoneum 
2. Primary hepatic tumours – Hepatocellular carcinoma,     
   Cholangiocarcinoma 
3. Primary Mesothelioma 
C. Chylous ascites 
1. Trauma to the thoracic duct 
2. Mediastinal tumours 
3. Filariasis 
4. Tuberculosis 
5. Cirrhosis (about 20% of patients) 
The protein concentration in cirrhotic ascites is determined 
almost entirely by the serum protein concentration and portal 
pressure.(29)  
 
Pitfalls in ascitic fluid total protein(3) 
1. A patient with cirrhosis and a relatively high serum protein 
concentration will have a relatively high ascitic fluid protein 
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concentration. Almost 20% of samples in patients with cirrhosis will 
have relatively high ascitic fluid protein concentration > 2.5 g/dl.  
2. The ascitic fluid total protein concentration does not increase 
during spontaneous bacterial peritonitis. It remains stable before, 
during of after infection. Infact patients with the lowest ascitic fluid 
protein concentrations are the most susceptible to spontaneous 
bacterial peritonitis. 
 3. During a 10 kg diuresis, the ascitic fluid total protein 
concentration doubles and 67% of such patients with cirrhotic ascites 
have a protein concentration greater than 2.5 g/dl by the end of 
diuresis. 
 4. In almost one third of patients with malignant ascites, the 
ascites is caused by massive liver metastasis or hepatocellular 
carcinoma and the ascitic fluid in these patients has a low protein 
concentration. 
 5. In cardiac ascites, the ascitic fluid protein concentration is 
greater than 2.5 g/dl.(27)
 Therefore the exudate / transudate method of classification of 
ascites places many patients with cirrhosis and ascites and all patients 
with cardiac ascites in the exudates category and many patients with 
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malignant ascites and essentially all patients with spontaneously 
infected ascites in the transudate category. Clearly this method of 
classification is not useful.  
 Serum ascites albumin Gradient:(3),(26),(30),(31),(38) 
                    In contrast to the ascitic fluid total protein, SAAG 
classifies fluid by the presence or absence of portal hypertension and 
is much more physiologic. The Starling hypothesis is the underlying 
physiology behind the estimation of SAAG. The SAAG is based on 
oncotic – hydrostatic balance. Portal hypertension results in an 
abnormally high hydrostatic pressure gradient between the portal 
bed and the ascitic fluid. A similarly large difference must exist 
between the ascitic fluid and the intravascular oncotic forces. 
Albumin exerts greater oncotic pressure than that exerted by other 
proteins. Therefore the difference between the serum and the ascitic 
fluid albumin concentrations correlates directly with portal pressure.  
                  The albumin gradient classifies cardiac ascites in the high 
SAAG category similar to cirrhotic ascites. The high SAAG of cardiac 
ascites is presumably the result of high right sided cardiac pressures.  
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Limitations of SAAG (19): 
 
1. The gradient may be falsely low, if the patients have a 
serum albumin < 1.1 g/dl and also in disease states 
with hyperglobulinemia. 
2. Errors may occur if the albumin assay is inaccurate in 
the low range, when the samples are not withdrawn at 
relatively same time and if the patient is in shock. 
3.  A falsely high value of SAAG may occur in chylous 
ascites as lipid fractions tend to interfere with 
laboratory determination of albumin.    
 
                The following chart depicts the classification of ascites on 
the basis of the values of SAAG with a cut off value as 1.1 into high 
SAAG and low SAAG ascites.  
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 Classification of Ascites by SAAG(3)
High gradient > 1.1 g / dl Low gradient < 1.1 g / dl  
Cirrhosis Peritoneal Carcinomatosis 
Alcoholic hepatitis Tuberculous peritonitis 
Cardiac ascites Pancreatic ascites 
Mixed ascites Bowel obstruction or infarction 
Massive liver metastasis Biliary ascites 
Fulminant hepatic failure Nephrotic syndrome 
Budd Chiari syndrome Post operative lymphatic leak 
Portal vein thrombosis Serositis in connective tissue 
disorders 
Sinusoidal obstruction syndrome  
Myxedema  
Fatty liver of Pregnancy  
 
 
 
 
 
 22
 
Differentiation of Ascites using Ascitic fluid Tests: (17) ,(25) 
 
Causes SAAG AFTP Other abnormalities 
Cirrhotic ascites > 1.1 < 2.5 AFTP > 2.5 during  diuresis 
Cardiac ascites > 1.1 > 2.5  
Peritoneal carcinomatosis < 1.1 > 2.5 Malignant cells in ascitic fluid  
Tuberculous peritonitis < 1.1 > 2.5 WBCs >500 / cu.mm. 
Lymphocytic predominance 
 
Chylous ascites 
< 1.1  < 2.5 Milky ascitic fluid. 
Triglycerides > 200 mg / dl 
Nephrotic syndrome < 1.1 < 2.5 Proteinuria 
Pancreatic ascites < 1.1 > 2.5 Ascitic Fluid amylase ( > 1000 
U/L) > Serum amylase 
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Classification of Ascites based on SAAG and AFTP (11) 
 
SAAG AFTP < 2.5 g / dl AFTP > 2.5 g / dl 
>/= 1.1  Cirrhosis, Fulminant 
hepatic failure, 
Alcoholic hepatitis, 
Liver metastasis, 
Chronic Budd Chiari 
syndrome, Sinusoidal 
obstruction 
syndrome,Portal vein 
thrombosis. 
Congestive heart 
failure, Myxedema, 
Acute Budd Chiari 
syndrome. 
< 1.1 Nephrotic syndrome  Peritoneal 
Carcinomatosis, 
Tuberculous 
peritonitis, Pancreatic 
ascites, Chylous 
ascites.   
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Portal Hypertension: 
Definition: (1) 
           Portal hypertension is defined as the elevation of the hepatic 
venous pressure gradient (HVPG) to > 5 mm Hg. Hepatic venous 
pressure gradient is equal to wedged hepatic venous pressure minus 
free hepatic venous pressure. 
Hemodynamic considerations: 
Pathophysiology of Portal hypertension: (7) 
           The pressure within the portal system is determined by the 
interaction of flow and vascular resistance. As these parameters 
change , so does the portal pressure. This relationship is expressed by 
Ohm’s law. 
D0 = Q X R, where D0 is change in pressure, Q is flow and R is 
resistance in a vessel. 
Resistance is determined by several factors as expressed in 
Poiseuille’s law,   
R = 8 n 3.14 Ll r4 , where n is the coefficient of viscosity, L is the 
vessel length and r , the vessel radius. 
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Within the liver, the viscosity and length of vessel are relatively 
constant, and changes in vascular resistance are mainly due to 
changes in radius. 
The normal liver has a very low intrahepatic resistance. This 
inherent property of an extremely compliant hepatic circulation can 
maintain normal portal pressure within a wide range of portal flow. 
This capacity is lost in liver disease with dramatic increase in 
intrahepatic resistances. Along with the structural disturbances in 
cirrhosis, inflammatory changes in the hepatic venous tree and 
deposition of fibrous tissue around the terminal hepatic venules and 
adjacent sinusoids have been described.   
In cirrhotic livers, intrahepatic resistance may also be affected 
by proliferation of myofibroblasts around the sinusoids and terminal 
hepatic venules resulting in increased contractility which may raise 
resistance and contribute to portal hypertension. These 
myofibroblasts are known as stellate cells. These are star shaped with 
branching arms and acquire contractile properties behaving in a 
similar manner to vascular pericytes. 
Thus in response to vasoactive substances such as endothelin, 
these cells by their action on the sinusoids, at the microcirculatory 
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level, can increase resistance to portal blood flow.  Sinusoids may be 
compressed by hepatocyte enlargement in regenerating parts of the 
liver. This can occur as a result of several toxic, infectious or 
metabolic insults to the parenchyma and may explain the portal 
hypertension in noncirrhotic conditions.   
Theories of Portal hypertension: 
Two major hypotheses have been advanced to explain this 
phenomenon.  
Backward theory: 
The backward theory postulates that portal hypertension is due 
to increased hepatic vascular resistance which develops as a specific 
response, so that in the presence of normal flow pressure increases. 
The hypertrophy of the myofibroblasts within the sinusoidal bed is 
one mechanism by which this could be achieved. In reality however, 
the portal and splanchnic circulation is not only markedly increased 
but hyperdynamic too, thus negating the likelihood that this theory 
can explain portal hypertension.      
Forward theory: 
The forward theory was initially postulated by Bantl et al. in 
1883. He suggested that splenomegaly, portal hypertension and  
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cirrhosis were the result of increased splanchnic arterial blood flow. 
The theory suggests that the increased and hyperdynamic flow 
together with the decreased splanchnic precapillary resistance 
maintain portal hypertension in the face of extensive portosystemic 
shunting.   
 Recent concept: 
More recently, Groszmann et al. and other workers have 
increasingly implicated that both the theories are being involved in 
the pathophysiology of the condition. It is currently believed that the 
principal and the initial abnormality is increased vascular resistance 
to portal flow and then portal hypertension is maintained by 
increased blood flow into the portal circulation, a phenomenon which 
has been confirmed conclusively both experimentally and clinically.  
Causes of Portal Hypertension: 
              The causes are usually subcategorized as prehepatic, 
intrahepatic and posthepatic.  
              Prehepatic causes of portal hypertension are those affecting 
the portal venous system, before it enters the liver. 
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                                         PREHEPATIC CAUSES 
1. Portal vein thrombosis 
2. Splenic vein thrombosis  
3. Massive splenomegaly 
  
                  Post hepatic causes encompass those affecting the hepatic 
veins and the venous drainage to the heart.  
                                      POST HEPATIC CAUSES               
1. Budd chiari syndrome 
2. Inferior venacaval webs 
3. Cardiac causes- a. Restrictive cardiomyopathy 
                                 b. Constrictive pericarditis 
                                 c. Severe CCF 
 
            Intrahepatic causes account for over 95% of causes of portal 
hypertension and are represented by the major forms of cirrhosis. 
Intrahepatic cause of portal hypertension can be further subdivided 
into pre sinusoidal, sinusoidal and post sinusoidal causes.  
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                                          HEPATIC CAUSES 
I.Presinusoidal 
a. Schistosomiasis      
                      b. Congenital hepatic fibrosis  
                      c. Sarcoidosis 
                      d. Vinyl chloride 
                      e. Drugs        
II. Sinusoidal 
                     a. Cirrhosis       
                     b. Alcoholic hepatitis 
                     c. Cystic liver disease 
                     d. Partial nodular transformation of the liver 
                     e. Metastatic malignant disease 
III. Post sinusoidal 
                     a. Hepatic sinusoidal obstruction 
                     b. Veno occlusive syndrome 
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MATERIALS AND METHODS 
  
               The study of ‘Serum Ascites Albumin Gradient in the 
etiological diagnosis of Ascites’ was carried out in the Department 
of General Medicine, Tirunelveli Medical College Hospital, 
Tirunelveli. 
 
Setting   : Medical Wards 
Study Design : Single centre observational prospective hospital  
  based study 
Period of study : June 2008 to June 2009 
Ethical approval : Obtained             
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METHODOLOGY 
               A total of fifty adult patients with ascites, admitted to the 
Department of General Medicine, Tirunelveli Medical College 
Hospital, Tirunelveli  with in an one year  period, whose etiological 
diagnosis had not been known previously were studied 
prospectively. The protocol was approved by the hospital’s ethical 
committee and an informed consent was obtained from all patients. 
         On entry, a detailed history and clinical examination were 
conducted. The fifty patients who satisfied the set criteria were 
included in the study. Paired ascitic fluid and serum samples were 
collected from them simultaneously and were examined for ascitic 
fluid albumin, ascitic fluid total protein and serum albumin with 
established methods of estimation – Bromocresol green and Biuret 
methods as described by Varley et al.   
Inclusion criteria:- 
 All patients with ascites due to any cause with normal 
coagulation profile. 
Exclusion criteria:- 
 Ascitic patients with severe   coagulopathy or disseminated 
intravascular coagulation (DIC). 
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Abdominal Paracentesis(3),(40)  
After obtaining informed consent from the patient and relatives, 
diagnostic abdominal paracentesis was done. The patients were asked 
to empty the bladder, prior to the procedure. 
 The skin of the abdominal wall was disinfected with an iodine 
solution. The skin and subcutaneous tissue were infiltrated with a 
local anaesthetic. A special technique was followed to prevent the 
leakage of fluid after the needle was withdrawn. This technique of 
needle insertion (Z tract) was accomplished by displacing the skin 
approximately 2 cms downward and then slowly inserting the 
paracentesis needle mounted on the syringe held in the other hand. 
The paracentesis needle is a steel 22 gauge needle about 1.5 inch in 
length. The hand holding the syringes was used to stabilize the 
syringes and to retract the plunger simultaneously. The skin was 
released only after the needle had penetrated the peritoneum. When 
the needle was ultimately removed, the skin resumed the original 
position and sealed the needle pathway. 
The needle was advanced slowly through the abdominal wall. 
Slow insertion helped to allow the bowel to move away from the 
needle thereby avoiding bowel puncture.  
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Site of needle insertion:- 
 The needle was inserted into the left lower quadrant rather than 
the right lower quadrant because the caecum may be distended with 
gas from lactulose therapy. In the presence of a surgical scar, the 
needle was placed several centimeters from the scar. 
 The ascitic fluid collected was sent for cell count in an EDTA 
bottle, biochemical analysis including total protein and albumin in a 
plain bottle and for cuture in a blood culture bottle. 
 Simultaneously blood samples were collected from the patients 
and were sent for the estimation of serum albumin to the laboratory. 
Calculation of SAAG 
 The serum ascites albumin gradient was calculated after 
measuring the serum and ascitic fluid albumin concentrations and 
simply subtracting the ascitic fluid value from the serum value. 
 To increase the accuracy of SAAG, specimens of serum and 
ascitic fluid were obtained simultaneously. 
Correction of SAAG 
 To correct the SAAG in the setting of a high serum globulin 
level the following formula was used. 
Corrected SAAG = Uncorrected SAAG x 0.16 x (Serum globulin + 2.5) 
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 Serum hyperglobulinemia (Serum globulin> 5 g/dl) leads to a 
high ascitic fluid globulin concentration and can narrow the albumin 
gradient by contributing to the oncotic forces. A narrow gradient 
caused by high globulin levels occurs in one percent of ascitic fluid 
specimens. 
Albumin estimation :- BCG method  
 The serum and ascitic samples for albumin are fed into the 
autoanalyser. 
Principle 
 Albumin in a buffered solution reacts with the anionic 
bromocresol green (BCG) with a dye binding reaction to give a 
proportionate green colour which is measured at 628 nm (600-650nm) 
Reagents. 
Reagent 1 (Bromocresol Green): 
Succinic acid 94 mmol/L 
Sodium hydroxide 10.2 mmol/L 
BCG 0.149 mmol/L 
Standard (Albumin 5g/dl) 
BSA 50g/L 
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Total protein (Biuret method) 
Principle: 
 Peptide bonds of protein form a blue violet coloured complex 
with cupric ions in an alkaline medium. The intensity of the colour is 
proportional to the number of peptide bonds and the colour is read at 
540 nm. 
Reagents. 
Reagents 1 (Biuret reagent) 
Sodium hydroxide 3.8 mol/L 
Potassium Sodium tartrate 0.1 mol/L 
Cupric sulfate 33 mmol/L 
Potassium iodide 30 mmol/L 
Reagent 1 A (Surfactant) 
Surfactant 20 g/l 
Standard (total protein 6g/dl) 
BSA 60 g/l 
All the 50 patients further underwent ultrasonogram abdomen 
which revealed the ultimate diagnosis for confirmation and 
comparing the diagnostic accuracies of SAAG and ascitic fluid 
protein. 
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 Ultrasonography of the liver and portal venous system, which 
is a noninvasive imaging modality, helped to establish the diagnosis 
of portal hypertension. USG diagnosis of portal hypertension was 
based on demonstration of  
a. Dilated collaterals around the gastroesophageal junction and 
splenic hilum,  
b. Splenomegaly and dilated portal vein >14 mm in diameter 
and splenic vein >12 mm.  
It also helped in establishing the etiology of portal hypertension 
by giving information about  
a.Hepatic architecture (altered echopattern with nodularity 
indicates cirrhosis, normal echopattern in extrahepatic portal vein 
obstruction and non cirrhotic portal fibrosis ) ,  
b. Patency of the portal and splenic veins (portal vein 
thrombosis and portal cavernoma diagnostic of EHPVO)  and 
c. Patency of hepatic veins and IVC. (thrombosis or Budd chiari 
syndrome)       
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OBSERVATION AND RESULTS 
The results of the diagnostic ascitic fluid aspiration and the 
ascitic fluid analysis in all the fifty selected patients are being 
interpreted here.  
The ascitic fluid specimens of fourty eight patients were straw 
coloured, whereas two specimens were hemorrhagic. After complete 
workup, one turned out to be a case of chronic calcific pancreatitis 
and and the other was a case of peritoneal carcinomatosis with 
primary in the large intestine.   
 
Table:1  Sex Distribution 
Males 26 
Females 24 
 
Table: 1 describes the distribution of ascites among the males 
and the females in the selected study group. The distribution of 
ascites among the males and the females was more or less equal with 
26 males and 24 females with a sex ratio of 1.08.  
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Sex Distribution in Ascites
Females, 
48%
Males, 52%
Females Males
 
 
Table:2 Age wise distribution 
Age(years)  Total 
11- 20 2 
21- 30 3 
31- 40 10 
41- 50 9 
51- 60 8 
61- 70 14 
71- 80 4 
Table: 2 outlines the distribution of ascites among the different 
age groups. It is quite interesting to note that the incidence of ascites 
increases as the age advances and the total number of cases peaks 
around 60 -70. The majority of the cases i.e. 45/50 (90%) are aged 
above 30 years, with a minority i.e. 5/50 (10%) below 30 years of age. 
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Age wise distribution in Ascites
4% 6%
20%
18%16%
28%
8%
11-20 21- 30 31- 40 41- 50 51- 60 61- 70 71- 80
 
Table:3 Comparison of age wise and sex wise distribution 
Age 
(years)  
Total Female Male 
11- 20 2 2 0 
21- 30 3 3 0 
31- 40 10 6 4 
41- 50 9 3 6 
51- 60 8 4 4 
61- 70 14 6 8 
71- 80 4 0 4 
Table:3 gives an outlook of the distribution of the age wise 
distribution of ascites among males and females. The minor group 
(10%) who presented below the age of thirty years were all females 
with no males. As the age advanced beyond 30 years of age, the 
incidence increased in both males and females with a maximum of 
males compared to females. Thus the incidence of ascites was more 
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among females in the younger age, whereas the incidence though 
increased both in males and females as the age advanced, it was 
higher in males (i.e.26/50 = 52%) when compared to females (i.e. 
19/50 = 38%).   
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Table: 4 Clinical profile: 
 Etiology Total  number 
Cirrhosis 28 
Decompensated heart failure 8 
Nephrotic syndrome 2 
Liver metastasis 1 
Peritoneal carcinomatosis 3 
Tuberculous ascites 5 
Pancreatitis 1 
Splenic abscess 1 
Hypothyroidism 1 
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Table: 4 interprets the etiological distribution of ascites among 
the study group. Considering the etiology of ascites in the population 
studied, cirrhosis of the liver (28 cases) ranked first followed by 
decompensated heart failure (8 cases), tuberculous peritonitis (5 
cases) and malignant ascites (4 cases). The other causes were 
nephrotic syndrome (2 cases), splenic abscess (1 case), pancreatitis (1 
case), spontaneous bacterial peritonitis (1 case) and hypothyroidism 
(1 case). 
Clinical Profile in Ascites
56%
16%
4%
2%
6%
10%
2% 2% 2%
Cirrhosis Decompensated heart failure
Nephrotic syndrome Liver metastasis
Peritoneal carcinomatosis Tuberculous ascites
Pancreatitis Splenic abscess
Hypothyroidism  
The cases who presented with ascites due to decompensated 
heart failure were evaluated. Among the 8 cases, there were 2 cases of 
valvular heart disease, 2 cases of corpulmonale, 2 cases of coronary 
artery disease with ischemic cardiomyopathy, 1 case of dilated 
cardiomyopathy and another case of restrictive cardiomyopathy. 
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There were 4 cases of malignant ascites among which 3 were 
cases of peritoneal carcinomatosis and the other one was a primary 
colonic carcinoma with secondaries in liver.  The primary tumours of 
peritoneal carcinomatosis were in ovary, stomach and large intestine. 
 
Table:5  Comparison of sex distribution and etiology of 
ascites  
Etiology Males Females Total 
Cirrhosis 19 9 28 
CCF 2 6 8 
Nephrotic syndrome 1 1 2 
Liver metastasis 0 1 1 
Peritoneal carcinomatosis 1 2 3 
TB Peritonitis 1 4 5 
Splenic abscess 1 0 1 
Pancreatitis 0 1 1 
Hypothyroidism 0 1 1 
 
Table: 5 gives an outline of the etiological distribution of ascites 
among both males and females. The most common cause of ascites 
among both the males and females was cirrhosis. Though cirrhosis 
was the common cause in both the genders, it constituted the major 
cause in males (i.e. 19/26=73%). However in females, the noncirrhotic 
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cases taken  altogether,  constituted the major group (i.e. 15/24=67%),  
whereas the cirrhotics constituted only the reminder (i.e. 9/24=33%).  
Among the non cirrhotic causes, decompensated heart failure 
topped the list with females about 75% (6/8) compared to males, 
followed by tuberculous peritonitis with females amounting 80% 
(4/5) and malignant ascites  with 50% females (2/4). 
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Table:6 Comparison of etiology of ascites and age wise 
distribution in males 
Etiology 11-20 21-30 31-40 41-50 51-60 61-70 71-80 Total 
Cirrhosis 0 0 3 6 3 6 1 19 
CCF 0 0 0 1 0 1 0 2 
Nephrotic 
syndrome 
0 0 1 0 0 0 0 1 
Liver metastasis 0 0 1 0 0 0 0 1 
Peritoneal Ca 0 0 0 0 0 0 1 1 
TB Peritonitis 0 0 0 0 1 0 0 1 
Splenic abscess 0 0 0 0 0 0 1 1 
 
Table:6 explains the distribution of ascites among different age 
groups in males. In males, cirrhosis is the leading cause peaking in 
the age group (61-70) followed by the age group (41-50). All the other 
causes of ascites like decompensated heart failure, hepatocellular 
carcinoma, peritoneal carcinomatosis, tuberculous peritonitis and 
splenic abscess presented beyond 40 years of age. Something 
interesting here is that no men presented below 20 years of age.  
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Distribution of ascites in males
72%
8%
4%
8%
4% 4%
Cirrhosis CCF Nephrotic syndrome
Peritoneal Ca TB Peritonitis Splenic abscess  
 
Table:7  Comparison of etiology of ascites and age wise 
distribution in females 
Etiology 11-20 21-30 31-40 41-50 51-60 61-70 71-80 Total 
Cirrhosis 0 0 3 0 2 4 0 9 
CCF 0 1 1 1 1 2 0 6 
Nephrotic 
syndrome 
0 0 1 0 0 0 0 1 
Peritoneal Ca 0 0 0 1 0 0 1 2 
TB Peritonitis 2 1 0 0 1 0 0 4 
Pancreatitis 0 1 0 0 0 0 0 1 
Hypothyroidism 0 0 0 0 0 1 0 1 
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Table:7 explains the distribution of ascites among different age 
groups in females. About 42% women (10/24) presented below 40 
years of age  and the remaining 58% women presented above 40 years 
of age. Tuberculous peritonitis was common amongst the younger 
individuals when compared to the old, whereas cirrhosis was 
common among the older individuals. Decompensated heart failure 
was equally prevalent in all age groups. Congestive cardiac failure 
and tuberculous peritonitis were common amongst females 
(10/24=42%) compared to males (3/26=12%).  
 
Distribution of ascites in females
38%
25%
4%
4%
4%
17%
4% 4%
Cirrhosis CCF Nephrotic syndrome
Liver metastasis Peritoneal Ca TB Peritonitis
Pancreatitis Hypothyroidism  
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Table: 8 Distribution of ascites on the basis of SAAG 
Etiology SAAG>/=1.1 SAAG<1.1 
Cirrhosis 26 2 
CCF 8 0 
Nephrotic syndrome 0 2 
Liver metastastasis 1 0 
Peritoneal carcinomatosis 0 3 
TB ascites 1 4 
Pancreatitis 0 1 
Splenic abscess 0 1 
Hypothyroidism 1 0 
 
Table:8 groups the individuals with ascites in the study 
population into high SAAG group and low SAAG group with a cut 
off value of 1.1.About 74% of the people were in high SAAG group 
and the left out 26% were in low SAAG group. 
Cirrhotic patients (26 cases), 8 cases of decompensated heart 
failure, a case each of liver metastasis, TB ascites and hypothyroidism 
had high SAAG ascites.  
4 cases of TB ascites, 3 cases of peritoneal carcinomatosis, 2 
cases of nephrotic syndrome, 2 cases of cirrhosis, 1 case each of 
pancreatitis and splenic abscess had low SAAG ascites. 
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Table: 9 Distribution of ascites on the basis of ascitic fluid total 
protein 
Etiology AFTP>/=2.5 AFTP<2.5 
Cirrhosis 9 19 
CCF 4 4 
Nephrotic syndrome 1 1 
Liver metastasis 0 1 
Peritoneal carcinomatosis 3 0 
TB peritonitis 4 1 
Pancreatitis 1 0 
Splenic abscess 1 0 
Hypothyroid 1 0 
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Table:9 classifies the ascites of the patients into two groups as 
exudative and transudative with the cut off of ascitic fluid total 
protein as >/=2.5 and <2.5 respectively. 48% of cases presented as 
exudative and 52% of cases had transudative ascites. 
After evaluating the patient with imaging studies and coming 
to the conclusion of the etiology, the patients were further classified 
into high SAAG or low SAAG, depending on the pathophysiology of 
ascites, whether related or unrelated to portal hypertension and 
exudative ascites or transudative ascites which are depicted in tables 
10 & 11. 
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Table:10  Classification of ascites depending on the 
Pathophysiology 
High SAAG No. Low SAAG No. 
Cirrhosis 28 Splenic abscess 1 
CCF 8 Pancreatitis 1 
Liver metastasis  1 Peritoneal carcinomatosis 3 
Hypothyroidism 1 TB peritonitis  5 
  Nephrotic syndrome 2 
 
     Table 10: groups the ascites into high SAAG and low SAAG 
depending on the pathophysiology. Cirrhosis, decompensated heart 
failure, liver metastasis and hypothyroidism were grouped under 
high  SAAG ascites. Peritoneal carcinomatosis, tuberculous ascites, 
nephrotic syndrome, splenic abscess and pancreatitis were grouped 
under low SAAG ascites. 
 Table: 11 Classification of ascites as exudative or transudative 
Exudate No. Transudate No. 
Peritoneal carcinomatosis 3 Cirrhosis 28 
Liver metastasis 1 Nephrotic syndrome 2 
TB Peritonitis 5 CCF 8 
Splenic abscess 1   
Pancreatitis 1   
Hypothyroidism 1   
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Table 11 groups the ascites as transudative and exudative after 
the etiology being identified. Cirrhosis, decompensated heart failure 
and nephrotic syndrome were grouped under transudative ascites 
whereas malignant ascites, tuberculous ascites, splenic abscess, 
hypothyroidism and pancreatitis were grouped under exudative 
ascites. 
Table: 12 Comparison of SAAG and Portal hypertension 
Pathophysiology High SAAG Low SAAG 
Portal HT 36 (True positive) 2 (False negative)  
Non Portal HT  1 (False positive)  11 (True negative) 
 
On comparing the high SAAG values and the presence of portal 
hypertension, 36 patients with high SAAG had a pathophysiology 
related to portal hypertension i.e true positive (a), whereas only one 
patient with high SAAG did not have portal hypertension i.e false 
positive (b). On the other hand, 11 patients with low SAAG did not 
have portal hypertension i.e true negative (d) and 2 patients with low 
SAAG had portal hypertension as its pathophysiology i.e false 
negative (c).These results are depicted in the Table:12.  
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Table:13  Comparison of AFTP and exudative/transudative  
 AFTP >2.5 AFTP<2.5 
Exudate 10 ( true positive) 2 (false negative) 
Transudate 14 (false positive) 24 (true negative) 
 
Comparing the values of ascitic fluid total protein and 
exudative/ transudative ascites , 12 patients with AFTP > 2.5 had 
exudative ascites  i.e true positive (a), whereas 16 patients with 
AFTP> 2.5 had transudative ascites  i.e false positive (b). However 20 
patients with AFTP <2.5 had transudative ascites i.e true negative (d) 
and 2 patients with AFTP < 2.5 had exudative ascites i.e false negative 
( c). These results are depicted in Table:13.  
1.Sensitivity is calculated by dividing true positive by the sum 
of true positive and false negative. i.e. (a / a+c )x 100. (14) 
2.Specificity is calculated by dividing true negative by the sum 
of true negative and false positive. i.e. (d/ d+b)x 100. 
3.Positive predictive value is calculated by dividing true 
positive by the sum of true positive and false positive i.e. ( a/ a+b) x 
100   
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4.Negative predictive value is calculated by dividing true 
negative by the sum of true negative and false negative i.e. (d/d+c) x 
100                                                                                   
5.Diagnostic accuracy is calculating by dividing the sum of true 
positive and true negative by the total number of cases and 
multiplying by 100. 
All the parameters were calculated separately for SAAG and 
ascitic fluid total protein using the above formulae. 
  
                ASCITIC FLUID TOTAL PROTEIN (AFTP) 
Sensitivity of AFTP = 10/(10+2)  x 100 = 83 % 
Specificity of AFTP = 24/(24+14) x 100 = 63% 
Positive predictive value of AFTP = 10/(10+14) x 100 = 42% 
Negative predictive value of AFTP = 24/(24+2) x 100 = 92% 
 
           SERUM ASCITES ALBUMIN GRADIENT (SAAG) 
Sensitivity of SAAG= 36/(36+2) x 100 =94% 
Specificity of SAAG= 11/(11+1) x 100 = 91% 
Positive predictive value of SAAG = 36/(36+1) x 100 = 97% 
Negative predictive value of SAAG = 11/(11+2) x 100 = 85% 
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DIAGNOSTIC ACCURACY 
Diagnostic accuracy =(True positive + True negative)/Total 
number of cases 
Diagnostic accuracy of AFTP = (10+24)/50  x 100 = 68% 
Diagnostic accuracy of SAAG = (36+11)/50 x 100 = 94%  
Table: 14 Comparison of AFTP & SAAG 
Parameters AFTP SAAG 
Sensitivity 83% 94% 
Specificity 63% 91% 
Positive predictive value 42% 97% 
Negative predictive value 92% 85% 
Diagnostic accuracy 68% 94% 
 
                            SAAG IS BETTER THAN AFTP 
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   The five variables   calculated for both AFTP and SAAG are 
depicted in table: 14. At a glance from this table, one could 
understand easily and with no doubt that SAAG is better than AFTP 
in determining the etiology of ascites, which is the aim of the present 
study.  
 
 
DISCUSSION 
 The results of the study “SAAG in the etiological diagnosis  of 
ascites” conducted in the medical wards of Tirunelveli medical 
hospital  has yielded an etiological profile of the entire study group  
as follows : 
 1.Liver cirrhosis – 56% 
 2.Decompensated heart failure – 16% 
 3.Tuberculous peritonitis – 10% 
 4.Malignant ascites – 8% including 3 cases of peritoneal 
carcinomatosis and 1 case of malignant deposit in liver    
5. Nephrotic syndrome – 4% 
6. Splenic abscess – 2% 
7. Pancreatitis – 2% 
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8. Hypothyroidism – 2% 
 
In a study(52) conducted by U.H.Malabu et.al.,I.O.Olubuyide 
et.ai., M.E.Shaibu et.al and F. Olawuyi et.al. (2006)  in the 
gastroenterology unit, department of medicine, University college 
Hospital, Ibadan, Nigeria, the clinical profile was as follows : 44% 
liver cirrhosis, 23% TB peritonitis, 22% Malignant ascites , 6% heart 
diseases and 5% nephrotic syndromes. 
In another group of 132 people studied(53) by Al-Knavy BA et.al. 
at the division of Gastroenterology, King Saud University, Abha, 
Saudi Arabia, the clinical ranking and profile were similar to the 
previous one with 69.7% liver cirrhosis, 10.6% peritoneal tuberculosis, 
9.1% malignant ascites, 7.6% decompensated cardiac failure and 3% 
nephrotic syndrome.   
  In contrast to the two studies discussed above, decompensated 
heart failure ranked the second instead of tuberculous peritonitis, in 
the present study group. On the other hand the major causes of 
ascites are liver cirrhosis amd malignant ascites in the western 
population, whereas tuberculous peritonitis leads the list in the 
Asians and Blacks.  
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However it is important to note that there is a limitation to such 
studies in general. Statistics derived from hospital figures are biased 
and are only an approximate guide to the incidence of the disease in a 
community. What is seen in hospitals may represent only the tip of an 
iceberg. The present data must be interpreted in the knowledge of the 
defects inherent to such studies. 
The clinical profile of the low SAAG ascites in the present study 
group was 38% of tuberculous peritonitis, 25% of peritoneal 
carcinomatosis, 15% of nephrotic syndrome and other causes like 
pancreatitis and splenic abscess which accounted for 7% each. The 
present study is comparable to a study(50) conducted by Fariborz 
Mansour – Ghanaei et al., Afshin Shafaghi et al., Amir- Hossein 
Bagherzadeh et al., Mohammad- Sadegh Fallah et al. among 148 
patients over a 7 years period at the Gastrointestinal and liver 
diseases research centre, Gullan University of medical sciences, 
Gullan Province, Iran, which concluded that Tuberculous peritonitis 
should be considered in all patients with low gradient ascites in the 
developing countries. This is in contrast to the study(36) conducted by 
Runyon et al. which stated  malignant ascites as the commonest cause 
of low SAAG ascites in the developed countries.  
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Myxedema ascites is a rare entitiy  and hypothyroidism as a 
cause of ascites accounts for less than one percent. A case report(54) 
and review literature by Jeong – Seon Ji et al. and colleagues at the 
department of internal medicine and Pathology, College of Medicine, 
The Catholic University of Korea, Seoul, Korea had stated that in a 
review of 51 well documented cases of myxedema ascites the mean 
SAAG and ascites were 1.5 & 3.9 g/dl respectively. Similarly the sixty 
eight years old hypothyroid female in our study, presented with high 
protein and high SAAG ascites.    
In the present study, the patients with malignant ascites 
presented as two groups – one with high SAAG ascites comprising 1 
case of  secondaries liver comprising about 25%. The other group 
presented with low SAAG ascites consisting of 3 cases of peritoneal 
carcinomatosis comprising about 75%. A similar one(51),” the study of 
the clinical pattern of ascites due to malignancy” was conducted in 
Qatar, by Khan F Y et al.,Ahmed M S et al., Lotf A Q et al. and 
Acsamawi M et al. during the year 2005 -2006, at Hamad General 
Hospital among 22 patients. The study revealed that SAAG was able 
to discriminate peritoneal carcinomatosis from other types of 
malignant ascites,  since it is related to the genesis of ascites and it is 
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very crucial in clinical practice. The diagnostic accuracy of SAAG in 
malignant ascites is 100% in our present study .  
The results of the application of the two tests of interest, i.e 
1. Serum ascites albumin gradient (SAAG) & 
2. Ascitic fluid total protein (AFTP) 
in the categorization of etiology of ascites in the study 
population are expressed in terms of sensitivity, specificity , positive 
predictive value, negative predictive value and diagnostic accuracy 
calculated by the appropriate formulae as  already discussed.  
The sensitivity, specificity, positive predictive value, negative 
predictive value and diagnostic accuracy of SAAG are 94%, 91%, 97%, 
85% and 94% respectively as compared to 83%, 63%, 42%, 92% and 
68% respectively with ascitic fluid total protein (Table:14).These 
results clearly demonstrate that SAAG offers an excellent 
discrimination of  the causes of ascites. Similar observations have 
been  reported by other studies too.  
  In the study (52) conducted by Al-Kanvy BA et.al. in Saudi 
Arabia, two other parameters i.e. ascitic fluid lactic dehydrogenase 
and ascitic to serum ratio of total protein , in addition to SAAG and 
AFTP  were compared. Among all the four, SAAG had the highest 
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poitive and negative predictive values  (80% & 98%) against that of 
ascitic fluid total protein ( 68% & 96%).    
There are two Indian studies(51),(39) which were conducted in 
Aligarh and Allahabad regarding the comparison of the accuracies of 
SAAG and AFTP in diagnosing the etiology of ascites. In the study of 
76 patients at the department of medicine, JN medical college, 
Aligarh Muslim University by M. Beg et al., S.Hussain et al., 
N.Ahmad et al. and N.Akhtar et al. the diagnostic accuracy and 
sensitivity of SAAG were 96% & 68% against the respective values 
68% & 66% of AFTP. In the other study, conducted at the department 
of Gastroenterology and Pathology, M.L.N Medical college, 
Allahabad, by Gupta.R et al., Misra.SP et al., Dwivedi.M et al., 
Misra.V et al., Kumar.S et al. and Gupta SC et al., the diagnostic 
accuracies of AFTP and SAAG were found to be 88% & 92% 
respectively. 
All these studies were based on the initial study(26) conducted 
by Bruce A. Runyon et al., Agnes A.Montano et al.,Evanengolos A. 
Akriviadis et al., Mainor R.Antillon et al.,Michelle A.Irving et al. and 
John G. McHutchison et al. among 901 patients in the University of 
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Iowa, Iowa city in the year 1992. The diagnostic accuracy of SAAG 
and ascitic fluid total protein were 96.7% and 55.6% respectively.      
In another study(38) conducted among 51 patients by Akriviadis 
EA et al., Kapnas D. et al., Hadjigraviel M. et al., Missiou A. et al. and 
Goulis J et al. in the University of Thressaloniki, Hippocratical 
Hospital, Greece the diagnostic accuracy of SAAG was found to be 
98%when compared to 52 – 80% in the four other diagnostic markers 
compared. (Ascitic fluid total protein, Ascites/Serum total protein 
ratio, Ascitic lactate dehydrogenase concentration and Ascites/Serum 
lactate dehydrogenase ratio). 
 
    Table:15 Comparison of the  
diagnostic accuracies of SAAG & AFTP as per etiology 
Etiology SAAG AFTP 
Cirrhosis 92% 68% 
CCF 100% 50% 
CRF 100% 50% 
Malignant ascites 100% 75% 
TB peritonitis 80% 80% 
Miscellaneous (Splenic abscess, 
Hypothyroidism & Pancreatitis)   
100% 100% 
                t = 2.72 (p < 0.05) 
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The diagnostic accuracy of SAAG and AFTP were calculated  
separately (Table:15) for each cause in the present study and they 
were compared statistically using student’s t test to determine the 
95% confidence interval. A p value < 0.05 is considered significant.  
The calculated t value is 2.72. (p < 0.05). For 10 degrees of 
freedom the table value is 2.23 at 5% level of significance, which is 
lesser than 2.72. So the data is significant at 5% level of significance 
and implies that SAAG is a better diagnostic measure than ascitc fluid 
total protein.       
Thus Serum ascites albumin gradient (SAAG) is the single best 
test against ascitic fluid total protein (AFTP), in the differential 
diagnosis of ascites. The terms exudative and transudative can be 
replaced by high SAAG and low SAAG ascites. This result is similar 
to the results of all the studies conducted(42),(43),(48),(47),(45) . 
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CONCLUSION 
The study “Serum ascites albumin gradient in the etiological 
diagnosis of ascites” conducted among the fifty inpatients with 
ascites, in the wards of the Department of General Medicine, at 
Tirunelveli Medical College Hospital has concluded that  
1. The sensitivity and specificity of SAAG in the differentiation 
of different types of ascites are 94% and 91% respectively. 
2. The  accuracy of SAAG in the etiological diagnosis is 94%.  
3. The serum ascites albumin gradient (SAAG) is superior to 
ascitic fluid total protein (AFTP) in the differential diagnosis of ascites 
and it is statistically significant. 
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                                 FUTURE PERSPECTIVE 
A number of studies since 1991 till date have proved the 
efficacy of SAAG in the differential diagnosis of ascites. As a result, 
SAAG has started replacing the age old exudate-transudate concept 
in the etiological diagnosis of ascites, in most of the institutions.   
Hence, further studies(37),(49) are aimed at concentrating the 
correlation between the value of SAAG and the complications of 
portal hypertension like esophageal varices leading on to upper 
gastrointestinal bleeding. 
In case, these studies could yield certain satisfactory and 
significant results, the SAAG value can be used as a screening tool to 
predict upper GI bleed. Moreover, the patients with portal 
hypertension could be put on prophylactic therapy considering the 
significant SAAG value, so that the mortality and morbidity in these 
patients can be reduced.  
In a nutshell, further studies are expected to extend the use of 
SAAG, beyond the differential diagnosis of ascites, such as 
complications and management of ascites.  
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PROFORMA 
 
Name :                               Age :                    Sex : 
 
Place :                              Occupation:                    
    
Chief complaints: 
 
Past History: 
 
Personal history: 
 
General examination: 
Examination of Major systems: 
Abdominal examination: 
Examination of the Cardiovascular system: 
Examination of the Respiratory system: 
Examination of the Central nervous system 
 
 
Investigations: 
1. Urine albumin, 24 hours urinary protein, sugar, deposits, bile 
salts and bile pigments.  
2. Complete blood count 
3. Blood urea, sugar, Serum creatinine and electrolytes.   
4. Liver function tests – Serum bilirubin, SGOT, SGPT,  alkaline 
phosphatase, Total protein, Albumin, Globulin, Prothrombin 
time. 
5. Ascitic fluid analysis – cell count, cytology, protein, albumin, 
glucose, amylase, adenosine deaminase, Gram’s stain, AFB & 
culture and sensitivity. 
6. ECG in all leads 
7. Xray chest PA view 
8. USG Abdomen and Pelvis 
9. CT scan abdomen and Echocardiogram in selected cases      
10. Thyroid Profile 
11. Serum amylase  
12. Serum adenosine deaminase 
13. Upper GI endoscopy 
14. FNAC of the peritoneal nodules.  
MASTER CHART 
 
Sl. 
No Name  IP no Age Sex 
Serum 
albumin
Ascitic 
fluid 
albumin 
SAAG Ascitic fluid total protein Etiology 
1.         Muthiah 26176 32 M 2.5 0.5 1.0 2.0 Nephrotic syndrome
2.         Mohamed Yosuf 25199 55 M 3.7 1.2 2.5 3.7 Cirrhosis 
3.         Ramakrishnan 35307 62 M 2.8 1.1 1.7 2.4 Cirrhosis
4.         Jenetus 29330 33 M 2.9 0.3 2.6 0.6 Cirrhosis
5.          Subramanian 22925 45 M 2.9 2.1 0.8 5.1 Cirrhosis
6.         Parvathiraja 28969 42 M 2.6 1.1 1.5 2.3 Cirrhosis
7.         Ganapathy 30412 36 F 1.6 0.5 1.1 2.8 Cirrhosis
8.          Shenbagammal 31210 62 F 3.7 2.4 1.3 4.0 RHD/AF/CCF
9.         Ganapathy 31215 32 F 2.0 1.0 1.0 3.0 Nephrotic syndrome
10. Kavitha 31320 32 F 3.0 1.0 2.0   2.0 CCF Corpulmonale
11. Lakshmi 31414 75 F 3.0 2.0 1.0 4.9  Peritoneal Carcinomatosis
12. Subramanian 31435 68 M 2.5 1.1 1.4 2.0 DCM 
13. Velladurai 31472 69 M 3.0 0.7 2.3 2.0 Cirrhosis  
14. Arulraj 31489 42 M 2.1 0.3 1.8 0.4 Cirrhosis 
15. Velladurai 32459 42 M 3.0 1.8 1.2   3.4 COPD/ Corpulmonale
16. Paldurai 33422 72 M 3.6 2.6 1.0   4.9 Peritoneal Carcinomatosis
17. Gomathy 34868 51 F 2.3 0.6 1.7 1.0 Cirrhosis 
18. Lakshmi 34629 62 F 3.8 3.1    0.7 7.0 Cirrhosis
19. Prema 34601 13 F 4.2 2.6    1.6 6.8 TB ascites
20. Chinthanamma 34072 35 F 2.0 0.6 1.4 1.0 Cirrhosis 
21. Katheeja Beevi 32766 55 F 2.1     0.7 1.4 2.1 Cirrhosis
22. Balu 33901 53 M 3.5 2.2 1.3 6.3 Cirrhosis 
23. Lakshmi 34977 65 F 3.0 1.8    1.2 2.0 Cirrhosis
24. Thilagar 35109 72 M 3.2 2.4 0.8 4.0 Splenic  abscess 
25. Ramajeyam 33424 72 M 3.2    0.5 2.7 2.3 Cirrhosis 
26. Sinthammal 33520 68 F 2.0 0.3 1.7 4.0 CCF 
27. Patchaikani 35385 55 M 2.4     0.8 1.6 1.2 Cirrhosis
28. Karuppasamy 32791 62 M 2.2     0.5 1.7 2.0 Cirrhosis
29. Palpandi 32852 35 M 2.7 0.9    1.8 2.0 Liver metastasis
30. Subramanian 32950 52 M 3.0 2.0   1.0 2.4 TB ascites  
31. Marimuthu 35722 48 M 3.5 1.4 2.1 2.3 Cirrhosis 
32. Sivanammal 37388 54 F 3.0 1.4 1.6 2.0 CCF 
33. Sankarapandi 37412 65 M 2.4     0.5 1.9 0.7 Cirrhosis
34. Jothi 37225 32 F 3.0 1.2 1.8 2.0 Cirrhosis 
35. Chandhramohan 37136 47 M 2.3 0.5 1.8 4.7 Cirrhosis 
36. Palanisamy 37103 65 M 3.3 0.4 2.9 0.6 Cirrhosis 
37. Muthulakshmi 40743 15 F 3.6 2.7 0.9 6.2 TB ascites 
38. Subbulakshmi 40834 43 F 2.0 0.8 1.2 1.9 CCF 
39. Chelladurai 37685 37 M 3.0 1.8 1.2 4.0 Cirrhosis 
40. Sumathy 40829 30 F 3.9 2.9 1.0 4.0 TB Ascites 
41. Arumugathammal 37702 63 F 3.1     1.0 2.1 3.1 Cirrhosis
42. Sivanammal 37388 54 F 3.0 2.6    0.4 3.1 TB Ascites
43. Esakkimuthu 42252 67 M 3.6 2.0 1.6 3.7 Cirrhosis 
44. Chelladurai 43170 52 M 3.0 1.3 1.7 2.3 Cirrhosis 
45. Esakkiammal 42054 45 F 3.0 2.0 1.0   3.4 Peritoneal Carcinomatosis
46. Annammal 43268 68 F 3.5 2.0   1.5 4.5 Hypothyroidism 
47. Gomathy 43163 65 F 3.2 1.8 1.4 2.2 Cirrhosis 
48. Krishnapriya 41899 24 F 3.0     2.0 1.0 3.1 Pancreatitis
49. Jothilakshmi 42863 25 F     3.7 2.5 1.2 6.4 CCF 
50. Chellapandi 43281 45 M 3.8     2.5 1.3 2.4 Cirrhosis
 
